Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

UV Monitoring Accessory

By Drug Discovery Trends Editor | September 7, 2010

CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce the introduction of its new UV Monitoring System, which is designed to work with CEM’s Liberty and Liberty1 Microwave Peptide Synthesizers. The UV Monitor increases the efficiency of the reaction and maximizes peptide quality, while reducing cycle times and reagent usage.

The system monitors the deprotection reaction, while the feedback control automatically adjusts the deprotection and coupling conditions in difficult regions of the peptide.

“We are very pleased to be adding UV monitoring capability to our line of microwave peptide synthesizers,” said Michael J. Collins, president and CEO of CEM Corporation. “The microwave peptide synthesis process already offers better yields much faster than conventional synthesis and the UV monitor takes that to the next level with the ability to refine the reaction even further for optimal results.”

Small and compact, the system features easy-to-use software that generates detailed UV data, as well as plug and play technology that is compatible with both new and older CEM microwave peptide synthesis systems. CEM’s groundbreaking microwave peptide synthesis technology and UV monitoring system are an unbeatable combination for faster synthesis of the highest quality peptides.

CEM Corporation


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE